Workflow
Cellectar Biosciences(CLRB) - 2024 Q1 - Earnings Call Presentation

Iopofosine I 131: U.S. WM Shares By Line of Therapy No Established Standard of Care Across All Lines of Therapy8 | --- | --- | --- | --- | |------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------|-------|--------------------------------------------------------------------------------------------------------------------------------------------------------------- ...